Reports Q4 revenue $100,000 vs. $1.63M last year. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on INBX: Inhibrx Biosciences Reports Promising Trial Results for INBRX-109 Inhibrx announces preliminary ozekibart data, initiates new expansion cohort Disclaimer & DisclosureReport an Issue
